Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Danel (Adir Yeoshua) Ltd (DANE.TA)
Ramat Gan, IL
Operating in Israel, Danel (Adir Yeoshua) Ltd specializes in delivering a comprehensive suite of human resource solutions. The firm's core offerings encompass talent acquisition (recruitment and placement), payroll administration, and project oversight. These services cater to a wide array of sectors, including welfare, education, diverse technological fields (such as high-tech, cleantech, and biotech), finance, insurance, general administration, and senior executive roles. Furthermore, the company provides dedicated nursing services. Beyond its HR portfolio, Danel also manages facilities focused on special education and assisting individuals with learning disabilities. Its extensive client base includes various government ministries, public sector entities, defense-related industries, and numerous private enterprises. Established in 1974, the company maintains its headquarters in Ramat Gan, Israel.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.27% | +2.60% | -2.03% | +6.19% | +2.91% | +0.25% | +19.25% | +99.92% | -24.89% | +281.61% | +3,556.88% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+4.9% Q1'26: +3.6% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+463.5% ★ Q1'26: +27.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+4.3% Q1'26: +3.6% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+7.0% Q1'26: +8.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+24.4% ★ Q1'26: +27.8% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+1.1% Q1'26: +2.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.08× ★ Q1'26: 0.97× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Israel ETF EIS | 0.17% | 1.52M | 0.59% |
| 2 | iShares Ageing Population UCITS ETF AGED.L | 0.06% | 504.9K | 0.40% |
| 3 | Schwab International Small-Cap Equity ETF SCHC | 0.03% | 1.41M | 0.06% |
| 4 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.02% | 48.9K | 0.83% |
| 5 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.02% | 2.94M | 0.40% |
| 6 | Dimensional - International Small Cap ETF DFIS | 0.02% | 1.16M | 0.39% |
| 7 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.02% | 2.73M | 0.06% |
| 8 | Dimensional - International Vector Equity ETF DXIV | 0.02% | 32.6K | 0.53% |
| 9 | Avantis Responsible International Equity ETF AVSD | 0.01% | 68.2K | 0.23% |
| 10 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 38.6K | 0.30% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Mizrahi | Chief Executive Officer | 3M | male |
| Ilan Ovadia | Chief Financial Officer | 2M | male |
| Eyal Zafrir | Chief Executive Officer of the Human Resources Division | — | male |
| Ronit Leviv | Vice President of Operations & Service | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DANE.TA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
